These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 8622643

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effect of formoterol and salmeterol on IL-6 and IL-8 release in airway epithelial cells.
    Strandberg K, Palmberg L, Larsson K.
    Respir Med; 2007 Jun; 101(6):1132-9. PubMed ID: 17229563
    [Abstract] [Full Text] [Related]

  • 23. Functional and binding characteristics of long-acting beta 2-agonists in lung and heart.
    Roux FJ, Grandordy B, Douglas JS.
    Am J Respir Crit Care Med; 1996 May; 153(5):1489-95. PubMed ID: 8630591
    [Abstract] [Full Text] [Related]

  • 24. Pharmacology of long-acting beta-agonists.
    Johnson M.
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):177-9. PubMed ID: 7648384
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Salmeterol-induced desensitization, internalization and phosphorylation of the human beta2-adrenoceptor.
    January B, Seibold A, Allal C, Whaley BS, Knoll BJ, Moore RH, Dickey BF, Barber R, Clark RB.
    Br J Pharmacol; 1998 Feb; 123(4):701-11. PubMed ID: 9517390
    [Abstract] [Full Text] [Related]

  • 30. Studies on the interaction between formoterol and salmeterol in guinea-pig trachea in vitro.
    Jeppsson AB, Källström BL, Waldeck B.
    Pharmacol Toxicol; 1992 Oct; 71(4):272-7. PubMed ID: 1360657
    [Abstract] [Full Text] [Related]

  • 31. In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action.
    Battram C, Charlton SJ, Cuenoud B, Dowling MR, Fairhurst RA, Farr D, Fozard JR, Leighton-Davies JR, Lewis CA, McEvoy L, Turner RJ, Trifilieff A.
    J Pharmacol Exp Ther; 2006 May; 317(2):762-70. PubMed ID: 16434564
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol.
    Nials AT, Sumner MJ, Johnson M, Coleman RA.
    Br J Pharmacol; 1993 Feb; 108(2):507-15. PubMed ID: 8095419
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s).
    Green SA, Rathz DA, Schuster AJ, Liggett SB.
    Eur J Pharmacol; 2001 Jun 15; 421(3):141-7. PubMed ID: 11516429
    [Abstract] [Full Text] [Related]

  • 40. Stable activation and desensitization of beta 2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite.
    Clark RB, Allal C, Friedman J, Johnson M, Barber R.
    Mol Pharmacol; 1996 Jan 15; 49(1):182-9. PubMed ID: 8569705
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.